Medline Inc.
MDLN
$34.05
-$0.64-1.85%
NASDAQ
| 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -81.98% | -59.94% | -37.02% | -0.62% | 13.46% |
| Total Depreciation and Amortization | 2.40% | 2.83% | 3.16% | 2.02% | 5.04% |
| Total Amortization of Deferred Charges | -13.33% | -26.67% | -6.67% | 0.00% | 11.11% |
| Total Other Non-Cash Items | 417.92% | 92.47% | 8.00% | -38.36% | 143.68% |
| Change in Net Operating Assets | 67.85% | -3,320.00% | 58.53% | -98.39% | -1,678.95% |
| Cash from Operations | 262.94% | -39.59% | 413.70% | -11.91% | -64.82% |
| Capital Expenditure | 22.38% | 2.04% | -51.65% | 5.61% | -72.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -222.38% | -4.35% | -42.27% | 89.88% | 28.14% |
| Total Debt Issued | -- | -- | -100.00% | 247.20% | -100.00% |
| Total Debt Repaid | -25,010.53% | -- | 35.86% | -182.27% | 99.47% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 16.67% | -- | -196,900.00% | -500.00% | 25.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 92.94% | -183.33% | -417.95% |
| Other Financing Activities | -- | -- | -350.00% | -- | -- |
| Cash from Financing | 51.52% | -44.44% | 164.35% | 71.15% | -293.51% |
| Foreign Exchange rate Adjustments | -122.22% | -177.78% | 50.00% | -50.00% | 500.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 135.55% | -49.83% | 163.03% | 144.38% | -147.99% |